NCT05264428

Brief Summary

This project investigates the effect of honey on lessening the withdrawal symptoms according to the body constitution.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 3, 2021

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

February 11, 2022

Completed
20 days until next milestone

First Posted

Study publicly available on registry

March 3, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 28, 2023

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2023

Completed
Last Updated

March 3, 2022

Status Verified

February 1, 2022

Enrollment Period

1.5 years

First QC Date

February 11, 2022

Last Update Submit

March 2, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fagerstrom Test for Nicotine Dependence

    Change from baseline Fagerstrom Test for Nicotine Dependence at 4 weeks, 3 and 6 months after the trial. Fagerstrom Test for Nicotine Dependence is ranged from 0-10. The higher score the higher dependence on Nicotine.

    Before and after the 4-week trial, 3 and 6 months after the trial

  • Minnesota Nicotine Withdrawal Scale

    Change from baseline Minnesota Nicotine Withdrawal Scale at 4 weeks. The Minnesota Nicotine Withdrawal Scale is ranged from 0-84. The higher score indicates more severe withdrawal syndromes.

    Before and after the 4-week trial

Secondary Outcomes (6)

  • Body Constitution Questionnaire

    Before and after the 4-week trial

  • Tobacco Craving Questionnaire

    Before and after the 4-week trial

  • Depression Anxiety Stress Scales-21

    Before and after the 4-week trial

  • WHOQOL-BREF

    Before and after the 4-week trial

  • Pittsburgh sleep quality index

    Before and after the 4-week trial

  • +1 more secondary outcomes

Study Arms (2)

Experimental group

EXPERIMENTAL

Participants need to drink honey every day for four weeks.

Dietary Supplement: Honey

Control group

PLACEBO COMPARATOR

Participants need to drink water every day for four weeks.

Dietary Supplement: Water

Interventions

HoneyDIETARY_SUPPLEMENT

Participants need to drink honey every day for four weeks.

Experimental group
WaterDIETARY_SUPPLEMENT

Participants need to drink water every day for four weeks.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • the cessation clinic patients aged more than 18
  • only take Champix for smoking cessation

You may not qualify if:

  • diabetes, cancer, renal disease
  • with wet and hot body constitution
  • allergic to honey
  • accepting traditional Chinese medicine intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hualien Tzu Chi Hospital

Hualien City, 970, Taiwan

RECRUITING

MeSH Terms

Conditions

Smoking CessationSubstance Withdrawal Syndrome

Interventions

HoneyWater

Condition Hierarchy (Ancestors)

Health BehaviorBehaviorSubstance-Related DisordersChemically-Induced DisordersMental Disorders

Intervention Hierarchy (Ancestors)

FoodDiet, Food, and NutritionPhysiological PhenomenaFood and BeveragesHydroxidesAlkaliesInorganic ChemicalsAnionsIonsElectrolytesOxidesOxygen Compounds

Central Study Contacts

Chung-shan Hung, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 11, 2022

First Posted

March 3, 2022

Study Start

September 3, 2021

Primary Completion

February 28, 2023

Study Completion

June 30, 2023

Last Updated

March 3, 2022

Record last verified: 2022-02

Locations